“…Similar to earlier studies, our large-scale registry showed that 7.1% patients underwent primary PCI presented with cardiogenic shock and, of these, 374 patients (56.6%) had MVD. These findings suggest that recent therapeutic improvements such as early revascularization strategy, inotropic agents, vasoconstrictors, adjunctive medications, and assist devices might contribute to improve survival, although in-hospital mortality of cardiogenic shock remains still high (16,17,23,24). There are several possible explanations for relatively low mortality in our study.…”